Concepedia

Hongxing Pan

HP

32

Publications

3.7K

Citations

23

H-Index

2006

Active since

Affiliations

Jiangsu Provincial Center for Disease Control and Prevention(Current)

National Institutes for Food and Drug Control

Nanjing Medical University

Southeast University

Academy of Military Medical Sciences

Hongxing Pan is an author at Jiangsu Provincial Center for Disease Control and Prevention specializing in medicine, vaccination, and vaccine safety.

ORCID

Top concepts

Publications per year

2006–2023

32

Publications

32

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Yanjun Zhang, Gang Zeng, Hongxing Pan et al. · The Lancet Infectious Diseases · 2020 · 1.5K citations · Full text

A Novel Influenza A (H1N1) Vaccine in Various Age Groups

Fengcai Zhu, Hua Wang, Han-hua Fang et al. · New England Journal of Medicine · 2009 · 341 citations · Full text

Immunogenicity and safety of a third dose of CoronaVac, and immune persistence of a two-dose schedule, in healthy adults: interim results from two single-centre, double-blind, randomised, placebo-controlled phase 2 clinical trials

Gang Zeng, Qianhui Wu, Hongxing Pan et al. · The Lancet Infectious Diseases · 2021 · 284 citations · Full text

, , +8

Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial

Jingxin Li, Shipo Wu, Xiling Guo et al. · The Lancet Respiratory Medicine · 2022 · 164 citations · Full text

, , +8

Heterologous AD5-nCOV plus CoronaVac versus homologous CoronaVac vaccination: a randomized phase 4 trial

Jingxin Li, Lihua Hou, Xiling Guo et al. · Nature Medicine · 2022 · 158 citations · Full text

Rows per page

1–5 of 32